Qcm Cayman, Ltd. Arbutus Biopharma Corp Transaction History

Qcm Cayman, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$2.42 - $3.98 $24,696 - $40,615	-10,205 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$3.11 - $4.61 $31,737 - $47,045	10,205 New	10,205 $40,000
Q2 2021 Aug 10, 2021	SELL	$2.5 - $3.51 $31,820 - $44,675	-12,728 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.14 - $4.84 $39,965 - $61,603	12,728 New	12,728 $42,000

165

102M

649K

666K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $504M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Qcm Cayman, Ltd., based on Form 13F filings with the SEC.

Stay updated on Qcm Cayman, Ltd. with notifications on news.